|Adult stem cell infusion post heart attack|
|A Phase I, Double-Blind, Placebo-Controlled, Dose-escalation, Multicenter Study to Determine the Safety of Intravenous ex-vivo Cultured Adult Human Stem Cells (Provacel) following Acute Myocardial Infarction ; A Long-term Follow Up Study to Evaluate the S|
|Ruchira Glaser, MD|
|No longer recruiting|
Why is this study being done?
|This research study involves infusion after a heart attack with adult human stem cells which is an investigational agent. The main goal of this study is to find out if it is safe to give this investigational agent to people who have had a heart attack, what are the potential side effects, and what dose is best. This research is also being done to see if an infusion (medication given in a solution directly into the vein) with the investigational agent can improve recovery from a heart attack. |
Who can I contact for additional information on this trial?
|Terry Mannion, RN, MS